Remed Co.,Ltd. (KOSDAQ:302550)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,405.00
-60.00 (-1.73%)
At close: Jul 18, 2025, 3:30 PM KST
17.41%
Market Cap107.24B
Revenue (ttm)26.68B
Net Income (ttm)7.71B
Shares Out31.50M
EPS (ttm)239.58
PE Ratio14.21
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume42,905
Average Volume308,062
Open3,495.00
Previous Close3,465.00
Day's Range3,395.00 - 3,495.00
52-Week Range2,800.00 - 4,420.00
Beta0.70
RSI41.59
Earnings DateAug 13, 2025

About Remed

Remed Co.,Ltd. engages in the manufactures and supplies of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as tinnitus, insomnia, dementia, stress, anxiety, etc. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In addition, the company provides e... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2003
Employees 87
Stock Exchange KOSDAQ
Ticker Symbol 302550
Full Company Profile

Financial Performance

In 2024, Remed's revenue was 25.55 billion, an increase of 37.86% compared to the previous year's 18.54 billion. Earnings were 7.17 billion, an increase of 799.69%.

Financial Statements

News

There is no news available yet.